Depiction of Prostate Cancer Treatment Alternatives in Greece
Study identifier:NIS-OGR-DUM-2007/1
ClinicalTrials.gov identifier:N/A
EudraCT identifier:N/A
CTIS identifier:N/A
Study Complete
Official Title
Depiction of Prostate Cancer Treatment Alternatives in Greece
Medical condition
Locally advanced or metastatic Prostate Cancer.
Phase
-
Healthy volunteers
No
Study drug
-
Sex
Male
Actual Enrollment
310
Study type
Observational
Age
18 Years +
Date
Study Start Date: 01 Jan 2008
Primary Completion Date: -
Study Completion Date: 01 Mar 2009
Study design
Allocation: -
Endpoint Classification: -
Intervention Model: -
Masking: -
Primary Purpose: -
Verification:
Verified 01 Nov 2013 by AstraZeneca Pharmaceuticals
Sponsors
AstraZeneca Pharmaceuticals
Collaborators
-
Inclusion and exclusion criteria
Loading...
No locations available
| Arms | Assigned Interventions |
|---|
Contacts
Contact
AstraZeneca Greece Medical Affairs & Health Economics Clinical Study
Investigators
Principal Investigator
Panagiotis Pontikis
AstraZeneca Greece
